James Parker

A portrait of the author.

James Parker

James Parker is a news writer and fact-checker from Coral Springs, Florida. He majored in Communication and Media Studies at Stetson University, where he spent much of his time examining the role of optics in various fields. When not covering the latest medical or legal development, James works on personal writing projects and board game design.

Latest MedTruth Work by James Parker

Image of a golfer placing a ball on a tee in the grass, representing Gary Lindeblad's Roundup lawsuit.

Golf Pro Sues Monsanto, Claims Roundup Caused Cancer

James Parker · September 16, 2020

A Washington state golf pro who says Roundup caused his cancer has filed a lawsuit against Monsanto. 

Legal Developments
Image of the state capitol in Missouri representing the J&J talc appeal.

Johnson & Johnson Talc Appeal Reaches Missouri Supreme Court

James Parker · September 11, 2020

J&J is asking the Missouri Supreme Court to overturn a multibillion-dollar ruling that affirmed that asbestos and carcinogens in its talc products caused cancer in 22 women.

Legal Developments
Image of a woman holding her glasses and rubbing her eyes due to vision damage from Elmiron.

Elmiron Lawsuits Claim Drug Companies Knowingly Withheld Risks

James Parker · August 25, 2020

Two women allege that drug manufacturers knowingly withheld information about harm caused by long-term use of Elmiron.

Legal Developments
Image of Metformin pills that were voluntarily recalled.

Additional Metformin Lots Voluntarily Recalled Due to Contamination Concerns

James Parker · July 16, 2020

The FDA issued a pair of new recall alerts for select extended-release batches of metformin, a popular drug used to control type 2 diabetes.

FDA Regulation
Image of a spray bottle representing the documentary STINK on Netflix.

“STINK!” Exposes the Odious Chemical Practices of Corporations in America

James Parker · July 10, 2020

The documentary STINK! follows the personal story of how Jon J Whelan became involved in activism against toxic chemicals.

Health Features
Image of a brain scan representing PPI and dementia study.

PPI and Dementia Potentially Linked In New Study

James Parker · July 6, 2020

A recent study published in Alzheimer’s & Dementia, the journal of the Alzheimer’s Association,  investigated the methods by which proton pump inhibitors and dementia are connected.

Research + Findings
Woman going into an MRI machine representing the GBCA chemical toxicity suit.

GBCA Chemical Toxicity Suit Weathers Dismissal Claims

James Parker · July 2, 2020

The plaintiff claims that the GBCAs used in her MRIs in 2015 caused a condition known as gadolinium deposition disease (GDD) and a host of debilitating side effects.

Legal Developments
A newborn baby on a bed representing the Zofran bellwether delay.

Zofran Bellwether Delay Pushes Proceedings to 2021

James Parker · June 29, 2020

The multidistrict Zofran litigation has been further delayed to 2021 due to coronavirus concerns.

Legal Developments
Person on laptop during FDA reporting hiatus.

Adverse Event Reporting Resumes After COVID Hiatus

James Parker · June 24, 2020

The slowdown in adverse event reporting can be attributed to an official regulatory pause for a period of two months. 

FDA Regulation
A stock image of a woman with heartburn, representing Zantac lawsuit consolidation in California.

California Attorneys Seek to Consolidate Zantac Lawsuits

James Parker · June 12, 2020

Attorneys representing 40 plaintiffs in California have recently filed a petition to consolidate product liability cases against the manufacturers of the heartburn medication Zantac, which may cause cancer.

Legal Developments

Tobacco Companies Challenge LA County Vape Ban in California Federal Court

James Parker · June 10, 2020

A group of tobacco companies is pushing to legally overturn the Los Angeles County ban on flavored vape fluid, alleging the action is unconstitutional and unenforceable. 

Legal Developments

FDA Singulair Warning Cautions Patients of Psychiatric Risks

James Parker · June 9, 2020

The FDA Singulair warning addressed a troubling connection between the medication and an increased risk of neuropsychiatric events, including agitation and depression. 

FDA Regulation
Image of Remdesivir used for coronavirus treatment.

Remdesivir Study Muddies Waters For Medical Authorities

James Parker · June 3, 2020

COVID-19 patients administered the investigational antiviral drug remdesivir were 65% more likely to exhibit clinical improvement according to preliminary research findings announced Monday by Gilead Sciences, a California-based biopharmaceutical company.

Research + Findings
A stock photo of a person's hand typing, representing New York allowing for electronic filing of non-essential legal matters.

New York State Courts Gradually Reopening

James Parker · May 22, 2020

Courts in New York City starting the next stage of re-opening, allowing for electronic filing of non-essential legal matters using the New York State Electronic Filing System (NYSCEF).

Legal Developments

Nursing Home Execs May Lose COVID-19 Liability Protections

James Parker · May 21, 2020

Newly introduced legislation could unravel legal protections recently afforded nursing home executives and administrators in New York.

Legal Developments
A stock photo of white capsules representing Elmiron maculopathy side effects, in the recent lawsuit.

Johnson & Johnson Faces Elmiron Lawsuit for Allegedly Concealing Adverse Event Data

James Parker · May 18, 2020

A recent legal complaint filed in May by a Nevada woman named Tina Pisco claims Elmiron, a drug for interstitial cystitis, caused her to develop maculopathy — a degenerative disease of the retina that may permanently damage vision.

Legal Developments
Elderly people in a nursing home, representing the lawsuit protections for nursing homes due to coronavirus safety concerns.

States Enact Controversial Lawsuit Protections for Nursing Homes

James Parker · May 13, 2020

The nursing home industry has grown increasingly concerned about a potential onslaught of COVID-related lawsuits and has begun pushing for legal protection from what it says are crisis conditions beyond its control.

Laws + Congress
Judge's gavel representing the Daubert ruling on talcum powder-cancer link.

After 9 Months, Daubert Ruling on Talcum Powder-Cancer is Released

James Parker · May 1, 2020

The recent Daubert opinion, written by presiding Judge Wolfson after a nine-month deliberation, is a crucial ruling on the validity of the methods used by the expert scientific witnesses testifying in the talcum powder and ovarian cancer multi-district litigation.

Legal Developments
A photo of the Stature of Liberty, representing controversial U.S. re-opening plan.

MT Weekly: At-Home COVID Test Kits, Anti-Malarial Drug Side Effects

James Parker · April 24, 2020

MedTruth is highlighting this week's coronavirus-related updates. The FDA warns the public not to use anti-malarial drugs outside of hospitals, the agency approved an at-home coronavirus test collection kit, and the CDC predicts a second wave of infections as the nation reopens.

News
Orange opioid pill bottles representing new opioid lawsuits.

New Opioid Lawsuit Filings May Be on the Horizon

James Parker · April 21, 2020

More than 2,700 multidistrict-litigations are still pending in Ohio federal court, while new opioid lawsuit filings are being bounced back to local and tribal governments.

Legal Developments
A photo of saliva representing the COVID-19 test.

MT Weekly: FDA Fast-Tracks Coronavirus Saliva Test, CDC Guidance For Workers’ Return

James Parker · April 16, 2020

MedTruth is highlighting this week's coronavirus-related updates. A COVID saliva test has been fast-tracked, federal guidelines for relaxing social distancing, and how warm weather will — or wont — affect the coronavirus.

News
Man attached to infusion therapy machine representing the CME Pump Recall.

CME Pump Recall Initiated For Inaccurate Medication Dispensing

James Parker · April 13, 2020

CME America’s BodyGuard Infusion Pump Systems have been recalled due to potentially fatal defects in medication dispersal.

FDA Regulation
Image of a brain scan of an aneurysm patient, representing the FDA Pipeline embolization recall.

FDA Pipeline Recall Initiated to Protect Aneurysm Patients

James Parker · April 9, 2020

The FDA has recalled Medtronic's Pipeline Flex Embolization products after the organization discovered that the device could fracture during or after placement.

FDA Regulation
Nursing home staff pushing man in wheelchair, representing nursing home residents at risk from coronavirus.

Nursing Home Residents Remain at Risk From Coronavirus Despite Lockdowns

James Parker · April 7, 2020

Nursing homes are closed to all outside visitors and nonessential staff to protect residents from COVID-19, but they are still vulnerable to infection spread by staff members.

News
A photo of a diabetes patient learning about the risks of taking type 2 diabetes medications before surgery.

FDA Warns Patients to Stop Taking SGLT-2 Inhibitors Before Surgery

James Parker · April 3, 2020

The FDA released a warning about continuing the use of sodium-glucose co-transporter-2 inhibitors before surgery, informing patients that the class of diabetes medications could contribute to a higher risk of ketoacidosis.

FDA Regulation
Image of lab technician putting together e-cigarettes, representing the e-cigarette deadline postponement.

E-Cigarette Deadline Postponement Requested Amid COVID-19 Uncertainty

James Parker · April 1, 2020

The FDA filed a request with the courts to postpone the deadline for e-cigarette makers to prepare approval and testing justifications, a decision motivated by complications arising from COVID-19.

News
Nurse giving coronavirus vaccine to man, representing the J&J Covid contract for COVID-19 vaccine research.

J&J COVID-19 Contract Allocates $456 Million For Vaccine Research

James Parker · March 31, 2020

J&J signed a COVID-19 contract with the U.S. government for vaccine research, becoming the largest monetary amount spent on a vaccine project in history, despite not yet having a product in production.

News
A photo of an empty courtroom due to the  COVID-19 shutdown of courts.

Johnson & Johnson Talc Appeal Unhindered by COVID-19 Shutdown

James Parker · March 30, 2020

A Missouri appellate court set an April 24 date for Johnson & Johnson’s $4.69 billion talc appeal, despite the Missouri Supreme Court’s cancellation of all April arguments to reduce COVID-19 exposure.

Legal Developments
Image of courthouse representing the New York coronavirus restrictions permitting certain types of legal work.

NY Coronavirus Restrictions Permit "Essential" Legal Work

James Parker · March 27, 2020

With the recent order to increase social distancing protocols in New York, law firms are not considered an "essential business." However, specific types of legal work are deemed essential, such as emergency family hearings and criminal cases.

News
A mother holding her child's hand, representing delays to Zofran bellweather.

Zofran Bellwether Delay Halts Litigatory Momentum

James Parker · March 27, 2020

The first bellwether trial in the multidistrict litigation involving Zofran, an anti-nausea medication that may cause birth defects, has been indefinitely postponed.

Legal Developments
Image of eyeshadow on woman's fingers, representing the FDA finding asbestos in cosmetics.

FDA Finds Asbestos in Cosmetics, Consumer Protection Bill Introduced

James Parker · March 25, 2020

The FDA's year-long probe into potential asbestos contamination in talc-containing cosmetic products and baby powder is over, and the results are in: contamination was found in 9 out of 52 samples.

FDA Regulation
Photo of woman with Elmiron complications struggling to read.

Research Suggests Elmiron May Cause Complications With Vision

James Parker · March 19, 2020

Studies have shown an association between Elmiron complications and retinal abnormalities, which may cause difficulty in reading and adapting to changes in light.

Research + Findings
Map representing the coronavirus spread.

Understanding the Coronavirus: Myths & Prevention

James Parker · March 10, 2020

An overview of coronavirus symptoms, prevention measures, resources and myths debunked.

News
Illustration of a head representing mental illness and the Electrical Stimulation Devices ban.

FDA Bans Electrical Stimulation Devices After Identifying Substantial Risk

James Parker · March 5, 2020

The FDA has banned electrical stimulation devices, used for self-injurious or aggressive behavior, due to significant psychological and physical risks.

FDA Regulation
Man holding white pills representing Zantac multidistrict litigation.

Corporations Accused of Allowing Excess NDMA in Zantac MDL

James Parker · March 4, 2020

A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.

Legal Developments
Person holding a JUUL, representing the AG probe investigations into Juul Labs.

38 States Unite to Investigate JUUL Labs

James Parker · February 27, 2020

State attorneys general are leading a probe into whether Juul had illicitly marketed its e-cigarettes as smoking cessation aids despite not being approved by federal regulators for that purpose.

Laws + Congress
A photo of money, representing the February 2020 J&J talc fine.

J&J Fined More Than $180 Million for Asbestos Contamination

James Parker · February 6, 2020

A New Jersey jury imposed a now-reduced verdict of three-quarters of a million dollars in punitive fines to Johnson & Johnson.

Legal Developments
A stock photo of a judge writing a decision, representing the January 2020 Ethicon mesh judgement in California.

California Ethicon Mesh Judgement Results in $344 Million Fine for J&J

James Parker · January 30, 2020

Johnson & Johnson's subsidiary is set to pay $344 million for failing to inform consumers about the risks of transvaginal mesh.

Legal Developments
Doctor using a recalled Ethicon surgical stapler.

Ethicon Stapler Recall Removes Over 90,000 Units From Circulation

James Parker · January 27, 2020

The FDA is enforcing an Ethicon stapler recall after units were ejecting malformed staples.

FDA Regulation
A photo of a doctor using a stethoscope to listen to the breathing of an elderly man who developed respiratory complications from gabapentin.

FDA Gabapentinoid Warning Focuses on Respiratory Complications

James Parker · January 21, 2020

The FDA issued a warning about respiratory depression and serious breathing difficulties in patients using gabapentin. Certain factors, including pre-existing respiratory complications and opioid use, may increase the risk.

FDA Regulation
A photo of a file of legal complaint, representing the Boynton Beach Zantac lawsuit.

Boynton Beach Zantac Lawsuit Filed by Local Woman

James Parker · January 15, 2020

A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.

Legal Developments
A photo of white pills, representing the FDA's metformin probe to assess if it contains unsafe levels of NDMA.

FDA Metformin Probe Investigates Potential NDMA Hazard

James Parker · January 8, 2020

An investigation will determine whether the diabetes drug metformin contains dangerously elevated levels of the carcinogen NDMA, as part of a larger movement to examine a wide spectrum of medications for unsafe levels of contamination.

FDA Regulation
A photo of a woman sitting and facing a public meeting, representing the pending FDA asbestos identification meeting on asbestos in talc.

FDA Schedules Public Meeting to Assess Testing for Asbestos in Talc

James Parker · January 13, 2020

The public meeting may be crucial to qualifying expert witnesses for thousands of plaintiffs involved in national talcum powder cases.

FDA Regulation
A photo of an Asian pharmacist removing medications from the pharmacy shelf, representing the recent news around the FDA Ranitidine recall.

More Companies Pull Heartburn Meds to Participate in FDA Ranitidine Recall

James Parker · January 13, 2020

Appco Pharma and Denton Pharma have voluntarily recalled generic versions of Zantac (ranitidine) to align with the FDA's efforts to remove drugs from circulation that may contain more than 96 nanograms of NDMA per million nanograms of ranitidine.

FDA Regulation
A photo of three teenagers hanging out near a school fence, reading about the PREVENT act to end vaping among teens on their cellphones.

PREVENT Vaping Act Seeks to Educate Teens About E-Cigarettes

James Parker · January 8, 2020

PREVENT, a bill introduced in the U.S. House of Representatives, intends to end the vaping epidemic among teens by supporting CDC efforts to educate youth about associated risks.

Laws + Congress
A stock photo of a woman signing a document, representing the recent midtrial settlement in the California talcum powder mesothelioma case.

Johnson & Johnson Settlement Abruptly Concludes California Talc Trial

James Parker · January 7, 2020

Johnson & Johnson and plaintiffs Linda and Mark O’Hagan reached a midtrial settlement without jury verdict, meaning the jury will not be given an opportunity to make a decision that considers the FDA's finding of asbestos in talcum powder.

Legal Developments
A photo of a justice scale representing the Los Angeles jury verdict which found in favor of Johnson & Johnson in a recent mesothelioma cancer case.

Los Angeles Jury Rules in Favor of Johnson & Johnson in Talc Mesothelioma Lawuit

James Parker · December 17, 2019

A jury in Los Angeles found Johnson & Johnson is not liable for causing Pui "Amy" Fong's mesothelioma, deciding its Baby Powder product was not defective nor a substantial threat.

Legal Developments
A photo of a medical assistant holding a duodenoscope, representing the recent FDA approval for a disposable, single use endoscopy device.

FDA Approves First Single-Use, Disposable Duodenoscope

James Parker · January 6, 2020

The Exalt Model D, manufactured by Boston Scientific, is the first single-use duodenoscope approved for physicians.

FDA Regulation
Woman buying vape liquid after the vaping tax bill was passed in Massachusetts

Massachusetts Passes Vaping Tax, Bans Mint and Menthol Tobacco Products

James Parker · December 9, 2019

A bill imposing a vaping tax and limiting the sale of mint and menthol flavored tobacco products has passed in Massachusetts.

Laws + Congress
Cannabis tincture representing the FDA CBD warning letters

FDA Warns CBD Companies For Violating Federal Law

James Parker · December 4, 2019

The FDA sent warning letters to 15 companies regarding the illegal sale of CBD products.

FDA Regulation
Photo of baby feet to suggest birth defects in Zofran litigation which are being disputed, despite removal of one supplemental study in October

Birth Defects in Zofran Litigation Disputed, Despite Evidence Removed

James Parker · November 13, 2019

Recent litigation on Zofran has called into question expert testimony, which was removed from the evidence indicating that Zofran causes birth defects when used by pregnant women. Drug manufacturer, GlaxoSmithKline denies that causation of complications beyond heart defects and cleft palate can be proved. Though five cases were removed from the compilation of suits against GSK, the court proceedings wage on -- calling into question whether or not GSK should be required to update their product labeling with an adequate warning.

Legal Developments
A photo of a phone and glasses to represent someone's desk as they sit down to read this week's MedTruth Weekly medical news report.

MT Weekly: Australia Fights BIA-ALCL, Ireland Refuses Recourse to Mesh-Injured

James Parker · October 21, 2019

Last week in medical brought about delay in an opioid trial against Purdue Pharmaceuticals and the Sackler family while the two determine how much of the settlement the Sacklers should pay. Meanwhile, actions were made against BIA-ALCL in Australia and Ireland, where warnings were sent to the public. Ireland's mesh-injured population is denied financial compensation for their harm.

News
Photo of phone, keyboard, and glasses on desk table to represent person about to read MedTruth Weekly.

MT Weekly: Research Sheds Light on BIA-ALCL, Australia Joins Litigation Against Monsanto

James Parker · October 14, 2019

Groundbreaking new research on breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) reveals complete removal of tumor growth during explant procedures may be safest. Meanwhile, limits on nicotine levels in e-cigarettes are proposed to protect the youth and Australia takes action against Monsanto.

News
A photo of a cell phone on a desk, representing MedTruth Weekly.

MT Weekly: Descovy Approved for PrEP, Overseas Action Against Breast Implants

James Parker · October 7, 2019

Johnson & Johnson sidesteps opioid trials, agreeing to a settlement of $20.4 million for affected counties in Ohio. Meanwhile, Descovy has been approved by FDA for HIV prevention, a court verdict falls in favor of California couple affected by J& J talc powder, and more bans are proposed on e-cigarattes and breast implants.

News
A photo of a cell phone on a desk, representing MedTruth Weekly.

MT Weekly: Arrests on Devil’s Highway and JUUL Labs’ New CEO

James Parker · September 30, 2019

Last week saw 38 arrests in Massachusetts along land known as the "Devil's Highway," where opioids are regularly sold. Meanwhile, Johnson & Johnson aims to evade cases against their talcum powder and transvaginal mesh to no avail. JUUL Labs' new CEO, Crosthwaite, has announced roll back on television ads and lobbying efforts while a federal investigation of their company is conducted. And in the fight against HIV, researchers may have found a new way to combat dormant HIV cells.

News
A photo of a cell phone on a desk, representing MedTruth Weekly.

MT Weekly: J&J Mistrial Declared, 'No JUULS' Requested for Schools

James Parker · September 16, 2019

In this week's MT Weekly, Purdue Pharma and the Sacklers negotiated settlements, while pharmaceutical manufacturer Mallinckrodt agreed to a $30 million settlement. Trials on talc and Roundup brought stalemates. Still, global HIV efforts and criticisms of JUUL e-cigarettes bring hope for public health.

Health Features
A photo of a cell phone on a desk, representing MedTruth Weekly.

MT Weekly: Robotic Devices for Breast Implants, Public Figures Protesting JUUL

James Parker · September 9, 2019

Our current installment of MT Weekly has updates on opioid epidemic initiatives, the J&J talcum powder trial, breast implant improvements, protests against JUUL and advancements in HIV research.

Health Features
A photo of a cell phone on a desk, representing MedTruth Weekly.

MT Weekly: Sackler Family Subpoenas, JUUL's Global Strategy, Momentous HIV Breakthroughs

James Parker · August 27, 2019

Last week, the state of New York issued subpoenas to companies with relations to the Sackler family in attempts to track money spent on opioids. Additionally, JUUL announced interest in global markets, and HIV researchers discovered a potentially illuminating sample of the virus.

Health Features
A photo of a cell phone on a desk, representing MedTruth Weekly.

MT Weekly: California Roundup Warnings, HIV Treatment Drawbacks, JUUL Sues FDA

James Parker · August 19, 2019

In recent news, Roundup will no longer be labeled as carcinogenic in California. Meanwhile, JUUL files suit against the FDA to delay inspection of their e-cigarette. Medicare defraud, talc trial asbestos denials and issues surrounding access to HIV prevention medication are also covered.

Health Features
A photo of vintage cigarette boxes to represent the new FDA Cigarette Warning Label plan.

FDA Will Add Graphic Warning Labels to Cigarette Packages

James Parker · August 15, 2019

On Aug. 15, the U.S. Food and Drug Administration released a new rule requiring warning labels on cigarette boxes. Full-color cigarette warnings must be included on all cartons with images of side effects, including blindness, amputation and bladder cancer.

FDA Regulation
Illustration of MRI scan of lungs for mesothelioma as the FDA approves the first mesothelioma treatment in 15 years.

First New Mesothelioma Treatment in 15 Years Approved by FDA

James Parker · August 8, 2019

Manufactured by Novocure, the FDA-approved mesothelioma treatment, NovoTTF-100L is the newest option for MPM since Pemetrexed. NovoTTF-100L was approved under the FDA Humanitarian Device Exemption, which is an expedited regulatory pathway intended to approve treatments for rare diseases.

FDA Regulation
A photo of a cell phone on a desk, representing MedTruth Weekly.

MT Weekly: JUUL Addresses Concerns, Bayer Faces Setbacks, Taiwan to Ban Transvaginal Mesh

James Parker · August 2, 2019

In this week's health news, JUUL addresses health concerns raised by Yale University's recent research findings on the well-known e-cigarette product. Meanwhile, Bayer stock drops as the company faces more litigation and transvaginal mesh bans are discussed in the U.S. and abroad.

Health Features
A photo of J&J's talcum powder products in relation to a recent lawsuit involving Claire's.

Seven Plaintiffs Refile J&J Talc Lawsuit to Prosecute Claire's and Others

James Parker · August 1, 2019

Judge George H. Wu of California granted case dismissal to seven plaintiffs in a talc lawsuit against Johnson & Johnson for their failure to label talc products. The plaintiffs will refile - adding more cases to their complaint and holding other companies liable.

Legal Developments
A photo of a mesh fence to resemble the latest transvaginal mesh trial where testimony stated that J&J Mesh Misleads Consumers with Marketing Tactics.

Marketing Tactics Mislead Consumers, Says Latest Testimony Against J&J Mesh

James Parker · July 31, 2019

In the latest transvaginal mesh trial, led by California Attorney General Xavier Becerra, expert testimony speaks to the way Johnson & Johnson's advertisements mislead consumers. Surgeon Margolis believes their mesh causes "substantial, significant, irreversible damage," despite consumer-friendly ads.

Legal Developments
A photo of a cell phone on a desk, representing MedTruth Weekly.

MT Weekly: Historic Breast Implant Recall, Talc Trials Kept in State Courts

James Parker · July 26, 2019

In this week's news, Johnson & Johnson is officially denied transfer into federal court and Allergen announces breast implant recall from the market worldwide. Meanwhile, the opioid crisis wages on, California's latest mesh trial proceeds, and solutions for HIV are sought around the globe.

News
A photo of a cell phone on a desk, representing MedTruth Weekly.

MT Weekly: Surprising Opioid Stats, HIV Research Strides and Stalled Zofran Litigation

James Parker · July 18, 2019

In this week's MT Weekly, recently published opioid statistics reveal that prescriptions for opioids are actually down by a notable percentage. Additionally, successful treatment methods for HIV are underway, and Zofran litigation is stalled by the pharmaceutical company's request for an FDA statement.

Health Features
A photo of a cell phone on a desk, representing MedTruth Weekly.

MT Weekly: Roundup Bans, Breast Implant Research and Medical Device Laws

James Parker · July 9, 2019

In recent news, Austria bans RoundUp while a U.S. judge orders a reduction of the $75 million punitive settlement. Numbers indicate a stronger correlation between BIA-ALCL and textured breast implants. The FDA also announced the end of their medical device alternative summary reporting system.

Health Features
Photo of woman holding opioids after Oklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids.

Oklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids

James Parker · June 25, 2019

Oklahoma's latest opioid trial revealed that Johnson & Johnson pressured doctors to sell "more and more opioids." During proceedings, It also came to light that J&J heavily profited from its two subsidiaries Noramco and Tasmanian Alkaloids - major players in U.S. opioid epidemic.

Legal Developments
Woman clutching stomach because of hernia mesh repair

Doctors Need More Info to Choose the Best Mesh for Hernia Repair

James Parker · May 21, 2018

A recent study shows hernia mesh labels lack important info, which could increase the risk of complications for patients.

Health Features
Hands in a circle representing talcum powder cancer case

22 Women Win Talcum Powder Cancer Case

James Parker · August 16, 2018

A Missouri jury awarded $4.69 billion to compensate women who reportedly developed talcum powder ovarian cancer, delivering the largest product-defect verdict in U.S. history.

Legal Developments
Man sitting on floor thinking about diabetes and depression

Are Diabetes and Depression Linked?

James Parker · July 19, 2018

Depression is the leading cause of disability worldwide. For diabetics, it can have a big impact on safety and self-care.

Health Features
A photo of pills on Plavix regarding the FDA update

FDA Dismissed Citizen Petition for Plavix Labeling

James Parker · January 18, 2019

The FDA recently dismissed a petition to add a new black-box label to the popular blood thinner Plavix.

FDA Regulation
A photo of talcum powder spilling out onto a table, representing J&J covering up asbestos in talcum powder.

Reuters Exposes How Johnson & Johnson Covered Up Asbestos in Talc

James Parker · December 18, 2018

An investigation shows Johnson & Johnson hid the fact that trace amounts of asbestos has been detected in their talc for decades.

News
Illustration of fist holding e-cigarette after vaping linked to seizures.

FDA Announces Intent to Look Into Potential “Vape Seizures”

James Parker · April 4, 2019

The U.S. Food and Drug Administration (FDA) announced today that they would begin looking into a potential link in a series of vape seizures that seem to be affecting young adults. The FDA became aware of the issue when conducting reviews of adverse event reporting related to vape use as part of their initiative to fully define the direct and indirect risks associated with the product.

FDA Regulation
Man with Diabetic Neuropathy holding foot

A MedTruth Guide to Diabetic Neuropathy

James Parker · May 23, 2018

Our guide to diabetic neuropathy delves into different types of nerve damage, associated symptoms and potential treatment options.

Health Features
A photo depicting a doctor talking with diabetes patient after FDA warns of rare genital gangrene linked to SGLT2 Diabetes Drugs.

FDA Warns of Rare Genital Gangrene Linked to SGLT2 Diabetes Drugs

James Parker · September 17, 2018

People with diabetes taking Invokana and other SGLT2 inhibitors may be at risk for Fournier's gangrene, a flesh-eating bacterial infection affecting the groin and genitals. SGLT2 inhibitors that may potentially cause Fournier's gangrene include Invokana, Farxiga and Jardiance.

FDA Regulation
Electric gate system safety

How to Stay Safe with Electric Gate Systems

James Parker · June 26, 2018

In the past 20 years, hundreds of people around the world have been injured or killed by an electric gate. Understanding automatic gate safety is key for both businesses and homeowners.

Health Features
Photo of Vape Juice bottles after FDA warns of relationship between vape juice and erectile dysfunction.

FDA Warns of E-Cig Burns, Erectile Dysfunction Drugs in Vape Juice

James Parker · November 16, 2018

As the FDA struggles to regulate e-cigarette marker, the agency has warned against e-cig burns, device explosions and even liquids containing erectile dysfunction drugs.

FDA Regulation
Photo of man exhaling smoke from e-cigarette after FDA makes JUUL Public Health Warning for use by minors.

FDA Takes A Stand Against The Flood of Underage Juul Users

James Parker · September 12, 2018

As the use of Juul vaporizers and other e-cigarettes among teens rises, the FDA reviews the company's youth marketing efforts and fines retailers for selling to minors.

FDA Regulation
Calorie Labels in Restaurant Menus

New Calorie Labels in Restaurants May Be Useful in the Fight Against Obesity

James Parker · June 1, 2018

Since early May, all restaurants with more than 20 locations are required to add calorie labels to their menus.

News
Talc in Cosmetics

Philippine FDA Warns of Talc in Cosmetics

James Parker · April 30, 2018

The Philippine FDA recently issued a consumer advisory about potential asbestos contamination in cosmetic talcum powder.

FDA Regulation
A photo of two executives signing an agreement following Oklahoma and Purdue Pharmaceuticals $270 million settlement.

Purdue Settles for $270 Million in Oklahoma's Opioid Crisis

James Parker · April 17, 2019

The state of Oklahoma and Purdue Pharmaceuticals have agreed to a $270 million settlement to help combat the crippling issue of opioid addiction in rural America.

Legal Developments
An illustration of a gavel representing the recent $25 million-dollar mesothelioma talc verdict in New York.

J&J Mesothelioma Talc Verdict in New York May Exceed $25 Million

James Parker · May 22, 2019

A New York jury issued a $25 million verdict against J&J for its part in causing a 66-year-old woman's asbestos-related cancer. The woman, Donna Olson, used J&J's talc products for decades.

Legal Developments
Woman holding clump of hair caused by Taxotere hair loss

Is Scalp Cooling a Treatment for Taxotere Hair Loss?

James Parker · May 14, 2018

The emergence of a new therapy known as scalp cooling may help women worried about permanent hair loss from Taxotere and other chemotherapy drugs.

News
Recalled pressure cooker

Pressure Cooker Recall: The Dangers of Defective Pressure Cookers

James Parker · June 8, 2018

A pressure cooker recall has been issued for multiple models that may explode, shock, or burn consumers. Because pressure cooker injuries can be serious, it's incredibly important to research recalled models and understand potential dangers.

News
How SSRI antidepressants affect sex drive

SSRIs and Sex: How Antidepressants Affect Desire

James Parker · July 31, 2018

SSRIs are commonly prescribed to help people living with anxiety or depression. Unfortunately, there may be a sexual caveat to these medications.

Health Features
US map representing OxyContin Lawsuit Against Perdue Pharmaceuticals

Half the Nation Unites Against Opioid Manufacturer

James Parker · July 6, 2018

In a crackdown attempt to fight the opioid crisis, 26 states are taking legal action against a major OxyContin manufacturer.

Legal Developments
Man wearing virtual reality headset to treat opioid addiction

Vanderbilt Tests VR Program To Treat Opioid Users

James Parker · April 23, 2018

An experimental therapy program, in development at Vanderbilt University, uses VR technology to treat opioid addiction.

MedTech